Charles River Laboratories International Inc
SWB:RV6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charles River Laboratories International Inc
SWB:RV6
|
US |
|
N
|
National Health Investors Inc
SWB:WX6
|
US |
|
Rockfire Resources PLC
LSE:ROCK
|
UK |
|
China Vanke Co Ltd
F:18V0
|
CN |
|
Swatch Group AG
OTC:SWGAF
|
CH |
|
W
|
Wendys Co
XBER:TQK
|
US |
|
H
|
HP Inc
BMV:HPQ
|
US |
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
BIO-Key International Inc
OTC:BKYI
|
US |
|
S
|
Scotts Miracle-Gro Co
XBER:SCQA
|
US |
|
AVG Logistics Ltd
BSE:543910
|
IN |
|
Montana Aerospace AG
OTC:MTASF
|
CH |
|
P
|
Puma SE
DUS:PUM
|
DE |
|
A
|
Akzo Nobel NV
OTC:AKZOF
|
NL |
Wall St Price Targets
RV6 Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for RV6 is 184.79 EUR with a low forecast of 124.19 EUR and a high forecast of 239.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV6's stock price target?
Price Target
184.79
EUR
According to Wall Street analysts, the average 1-year price target for RV6 is 184.79 EUR with a low forecast of 124.19 EUR and a high forecast of 239.05 EUR.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 15%.
